Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors

Table 2

Patient characteristics in the group with levodopa dispensation and with no levodopa dispensation.

	No levodopa redemption (n = 21047)	Levodopa redemption (n = 1911)
Proportion of men	37.55	54.47
Age distribution	24.19, 29.7, 26.2, 19.9	16.22, 36.05, 37.21, 10.52
Proportion with drugs for diabetes (none)	10.09	7.01
Proportion with drugs for hypothyroidism (none)	12.85	10.05
Proportion with drugs for hypertension (none)	15.14	11.93
Proportion with drugs for atrial fibrillation (none)	39.61	37.94
Proportion with first prescription for the MAO-B inhibitor/dopamine agonist from the specialist	0.97	2.62
Days observed	1800, 1717, 1, 3836	551, 277, 1, 3665

Age groups, 50–59, 60–69, 70–79, and 80+. Mean, median, min, and max.